Clinical Trials Contact Us Careers Search BioMarin to Participate in Four Upcoming Virtual Investor Conferences - Jefferies Gene Therapy/Editing Summit on October 28 at 2:30pm ET - Credit Suisse 30th Annual Healthcare Conference on November 10 at 1:50pm ET - Barclays Gene Editing & Gene Therapy Summit on November 15 at 4:00pm ET - Stifel 2021 Virtual Healthcare Conference on November 17 at 11:20am ET Oct 25, 2021 SAN RAFAEL, Calif., Oct. 25, 2021 /PRNewswire/ -- BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) today announced that management will participate in four upcoming virtual investor conferences. An audio webcast of the presentations will be available live. You can access the webcasts at: https://investors.biomarin.com/. An archived version of the remarks will also be available through the Company's website for a limited time following the conference. About BioMarin BioMarin is a global biotechnology company that develops and commercializes innovative therapies for patients with serious and life-threatening rare genetic diseases. The Company's portfolio consists of several commercialized products and multiple clinical and pre-clinical product candidates. For additional information, please visit www.biomarin.com. Information on such website is not incorporated by reference into this press release. Contacts: Investors Media Traci McCarty Debra Charlesworth BioMarin Pharmaceutical Inc. BioMarin Pharmaceutical Inc. (415) 455-7558 (415) 455-7451 SOURCE BioMarin Pharmaceutical Inc. Navigate Our Motivation Our Treatments Our Company Investors & Media About Our History Our Products Our Pipeline Leadership Team Board of Directors Diversity, Equity & Inclusion Contact Global Contact Information Our Locations Report a Product Complaint Report Adverse Event Publication Data Request Funding & Support Connect Careers LinkedIn Facebook Instagram YouTube Privacy Policy Terms of Use Site Map Supplier Information Slavery Act Statement Glossary Contact Us © 2021 BioMarin. All rights reserved.